Thursday, August 6, 2009

GlaxoSmithKline to buy Nabi product - Triangle Business Journal


GlaxoSmithKline to buy Nabi product
Triangle Business Journal
Nabi investors pushed the company's have (NASDAQ: NABI) up by 12 percent, or 30 cents, to $2.83 in after-hours trading on Thursday.

and more »
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)